The share
Cell Impact's share is listed on the Nasdaq First North Growth Market, a Nordic marketplace for small and medium-sized growth companies. The share is named Cell Impact B and the ticker symbol is CI, with the ISIN code SE0017885379.
Share graph
Owner List
Development of share capital and number of shares in 2025
As per 30 september 2025.
| Year | Event | Change share capital (SEK) | Change shares | Share capital (SEK) | Number of shares | Quota value (SEK) |
|---|---|---|---|---|---|---|
| 2025 | Opening values 1/1 2025 | 80,597,667.04 | 696,279,128 | 0.12 | ||
| 2025 | Reduction of share capital | -66,672,244.48 | – | 13,925,422.56 | 696,279,128 | 0.02 |
| 2025 | Rights issue | 39,231,526.56 | 1,961,576,328 | 53,156,949.12 | 2,657,847,456 | 0.02 |
| 2025 | Bonus issue | 29,073,604.00 | – | 82,230,553.12 | 2,657,847,456 | 0.03 |
| 2025 | Reduction of share capital | -29,073,604.00 | – | 53,156,949.12 | 2,657,847,456 | 0.02 |
| 2025 | Directed issue | 5,760,000.00 | 288,000,000 | 58,916,949.12 | 2,945,847,456 | 0.02 |
| 2025 | Share consolidation 1:10 | – | -2,651,262,711 | 58,916,949.12 | 294,584,745 | 0.20 |
Historic development
Historic development of share capital as of October 1, 2024
| Change | Number of shares | |||||||
| Year | Event | A shares | B shares | A shares | B shares | Total | Quota value | Share capital |
| 1999 | New establishment | 0 | 3,800,000 | 0 | 3,800,000 | 3,800,000 | 1.00 | 3,800,000 |
| 2012 | Directed share issue | 0 | 1,200,000 | 0 | 5,000,000 | 5,000,000 | 0.10 | 500,000 |
| 2012 | Reverse split | 0 | -680,574 | 0 | 4,319,426 | 4,319,426 | 0.12 | 500,000 |
| 2012 | Conversion | 72,600 | -72,600 | 72,600 | 4,246,826 | 4,319,426 | 0.12 | 500,000 |
| 2013 | Rights issue | 72,600 | 4,246,826 | 145,200 | 8,493,652 | 8,638,852 | 0.12 | 1,000,000 |
| 2016 | Directed share issue | 0 | 526,000 | 145,200 | 9,019,652 | 9,164,852 | 0.12 | 1,060,888 |
| 2016 | Rights issue | 72,600 | 4,509,826 | 217,800 | 13,529,478 | 13,747,278 | 0.12 | 1,591,332 |
| 2018 | Rights issue | 0 | 3,901,218 | 217,800 | 17,430,696 | 17,648,496 | 0.12 | 2,098,485 |
| 2018 | Directed share issue | 0 | 480,000 | 217,800 | 17,910,696 | 18,128,496 | 0.12 | 2,098,485 |
| 2018 | Directed share issue | 0 | 7,999,968 | 217,800 | 25,910,664 | 26,128,464 | 0.08 | 2,098,485 |
| 2019 | Rights issue | 0 | 18,128,496 | 217,800 | 44,039,160 | 44,256,960 | 0.06 | 2,638,677 |
| 2019 | Directed share issue | 0 | 1,191,701 | 217,800 | 45,230,861 | 45,448,661 | 0.12 | 5,260,962 |
| 2020 | Exercise of warrants | 0 | 6,393,673 | 217,800 | 51,624,534 | 51,842,334 | 0.10 | 5,260,962 |
| 2020 | Directed share issue | 0 | 7,000,000 | 217,800 | 58,624,534 | 58,842,334 | 0.12 | 6,811,362 |
| 2021 | Rights issue | 0 | 16,812,094 | 217,800 | 75,436,628 | 75,654,428 | 0.12 | 8,757,466 |
| 2022 | Restamping | -217,800 | 217,800 | 0 | 75,654,428 | 75,654,428 | 0.12 | 8,757,466 |
| 2022 | Exercise of warrants | 0 | 172,500 | 0 | 75,826,928 | 75,826,928 | 0.12 | 8,777,433 |
| 2023 | Rights issue | 0 | 515,623,104 | 0 | 591,450,032 | 591,450,032 | 0.12 | 68,463,980 |
| 2024 | Exercise of warrants | 0 | 104,821,096 | 0 | 696,271,128 | 696,271,128 | 0,12 | 80,597,667 |